Skip to Main Content

iRhythm Technologies, Inc

IRTC Real Time Price USD
138.69
+1.00
(0.72%)
As of today at 10:06 UTC-04:00
Add to Watchlist
Overview
Financials
Forecast
Insiders
Institutions
Government
Ownership
Income
Balance Sheet
Cash Flow
Revenue Breakdown

Recent trades of IRTC by members of U.S. Congress

IRTC Stock Insider Trading Activity
Name
Type
Shares
Price
Shares Held
Date
Reported
IRTC Stock Institutional Owners
Investor
Shares
Change in Shares
Market Value
Date
Reported
IRTC Derivatives Institutional Owners
Investor
Type
Shares
Change in Shares
Market Value
Date
Reported

Recently reported changes by institutional investors

Whales36.33333333New18Increased33Held23Decreased30Closed5

Quarterly net insider trading by IRTC's directors and management

2024Q22024Q32024Q42025Q12025Q2−70k−60k−50k−40k−30k−20k−10k0
Net Shares Purchased by Insiders

Government lobbying spending instances

  • $60,000 Apr 21, 2025 Issue: Medicare/Medicaid
  • $60,000 Jan 21, 2025 Issue: Medicare/Medicaid
  • $40,000 Oct 21, 2024 Issue: Medicare/Medicaid
  • $10,000 Oct 11, 2024 Issue: Health Issues Medicare/Medicaid
  • $60,000 Jul 19, 2024 Issue: Health Issues Medicare/Medicaid
  • $60,000 Apr 18, 2024 Issue: Health Issues Medicare/Medicaid
  • $60,000 Oct 19, 2023 Issue: Health Issues Medicare/Medicaid
  • $60,000 Jul 14, 2023 Issue: Health Issues Medicare/Medicaid
  • $60,000 Jan 19, 2023 Issue: Medicare/Medicaid
  • $60,000 Oct 19, 2022 Issue: Medicare/Medicaid
  • $60,000 Jul 20, 2022 Issue: Medicare/Medicaid
  • $60,000 Apr 20, 2022 Issue: Medicare/Medicaid
  • $30,000 Jan 20, 2022 Issue: Medicare/Medicaid
  • $40,000 Jan 18, 2012 Issue: Health Issues
  • $40,000 Oct 18, 2011 Issue: Health Issues
  • $40,000 Jul 20, 2011 Issue: Health Issues
  • $10,000 Apr 22, 2011 Issue: Health Issues

Estimated quarterly lobbying spending

20212022202320242025050k100k150k200k250k
Q4Q3Q2Q1Lobbying Amount

IRTC Revenue by Segment or Geography

By Segment
By Geography
Quiver Logo

No Revenue by Segment data for this ticker

Revenue Breakdown Dashboard
Quiver Logo

No Revenue by Geography data for this ticker

Revenue Breakdown Dashboard
IRTC Income Statement
IRTC Balance Sheet
IRTC Cash Flow
U.S. Patents

New patents grants

  • Patent Title: Physiological monitoring device Mar. 11, 2025
  • Patent Title: Physiological monitoring device Mar. 11, 2025
  • Patent Title: Physiological monitoring device Feb. 18, 2025
  • Patent Title: Wearable device Feb. 04, 2025
  • Patent Title: Device features and design elements for long-term adhesion Nov. 05, 2024
  • Patent Title: Adhesive physiological monitoring device Nov. 05, 2024
  • Patent Title: Methods and systems for processing data via an executable file on a monitor to reduce the dimensionality of the data and encrypting the data being transmitted over the wireless network Jun. 04, 2024
  • Patent Title: Non-invasive cardiac monitor and methods of using recorded cardiac data to infer a physiological characteristic of a patient Mar. 12, 2024
  • Patent Title: Wearable device with bridge portion Nov. 07, 2023
  • Patent Title: Wearable monitor Sep. 12, 2023
  • Patent Title: Wearable device with conductive traces and insulator Sep. 12, 2023
  • Patent Title: Physiological monitoring device Apr. 18, 2023
  • Patent Title: Wearable monitor Mar. 14, 2023
  • Patent Title: Wearable device with bridge portion Feb. 28, 2023
  • Patent Title: Electrical components for physiological monitoring device Nov. 22, 2022
  • Patent Title: Methods and systems for processing data via an executable file on a monitor to reduce the dimensionality of the data and encrypting the data being transmitted over the wireless Nov. 15, 2022
  • Patent Title: Wearable device with conductive traces and insulator Aug. 02, 2022
  • Patent Title: Non-invasive cardiac monitor and methods of using recorded cardiac data to infer a physiological characteristic of a patient Jul. 12, 2022
  • Patent Title: Methods and systems for processing data via an executable file on a monitor to reduce the dimensionality of the data and encrypting the data being transmitted over the wireless network Jul. 05, 2022
  • Patent Title: Wearable device with bridge portion Jun. 07, 2022
  • Patent Title: Adhesive physiological monitoring device Jun. 07, 2022
  • Patent Title: Electrical components for physiological monitoring device May. 24, 2022
  • Patent Title: Wearable monitor Mar. 29, 2022
  • Patent Title: Methods and systems for processing data via an executable file on a monitor to reduce the dimensionality of the data and encrypting the data being transmitted over the wireless network Feb. 22, 2022
  • Patent Title: Methods and systems for processing data via an executable file on a monitor to reduce the dimensionality of the data and encrypting the data being transmitted over the wireless network Feb. 22, 2022
  • Patent Title: Non-invasive cardiac monitor and methods of using recorded cardiac data to infer a physiological characteristic of a patient Feb. 15, 2022
  • Patent Title: Wearable device with conductive traces and insulator Feb. 15, 2022
  • Patent Title: Device features and design elements for long-term adhesion Oct. 12, 2021
  • Patent Title: Methods and systems for processing data via an executable file on a monitor to reduce the dimensionality of the data and encrypting the data being transmitted over the wireless network Aug. 10, 2021
  • Patent Title: Physiological monitoring device Jul. 06, 2021
  • Patent Title: Wearable monitor Oct. 27, 2020
  • Patent Title: Wearable monitor Jun. 02, 2020
  • Patent Title: Physiological monitoring device Feb. 11, 2020
  • Patent Title: Device features and design elements for long-term adhesion Dec. 31, 2019
  • Patent Title: Device features and design elements for long-term adhesion Sep. 10, 2019
  • Patent Title: Physiological monitoring device Jul. 16, 2019
  • Patent Title: Physiological monitoring device Jul. 02, 2019
  • Patent Title: Wearable monitor with arrhythmia burden evaluation May. 28, 2019
  • Patent Title: Physiological monitoring device Apr. 30, 2019
  • Patent Title: Wearable monitor with arrhythmia burden evaluation Oct. 16, 2018
  • Patent Title: Wearable monitor May. 01, 2018
  • Patent Title: Wearable monitor Mar. 21, 2017
  • Patent Title: Skin abrader Sep. 27, 2016
  • Patent Title: Device features and design elements for long-term adhesion Jan. 26, 2016
  • Patent Title: Skin abrader Nov. 03, 2015
  • Patent Title: Device features and design elements for long-term adhesion Oct. 15, 2013
  • Patent Title: Device features and design elements for long-term adhesion Sep. 17, 2013
Government Contracts

Federal grants, loans, and purchases

Government Contracts

Estimated quarterly amount awarded from public contracts

2023−1−0.500.51
Q4Q3Q2Q1Government Contracts Amount
IRTC News

Recent insights relating to IRTC

Quiver QuantitativeNew Insider Disclosure: Patterson Chad (Chief Commercial Officer) disclosed 8510 shares sold of $IRTCArticle Thumbnail
Quiver QuantitativeNew Insider Disclosure: Wilson Daniel G. (Chief Financial Officer) disclosed 2000 shares sold of $IRTCArticle Thumbnail
New Analyst Forecast: $IRTC Given 'Overweight' RatingArticle Thumbnail
$IRTC stock is up 17% today. Here's what we see in our data.Article Thumbnail
IRHYTHM TECHNOLOGIES Earnings Results: $IRTC Reports Quarterly EarningsArticle Thumbnail
iRhythm Technologies Presents AVALON Study Findings Demonstrating Superiority of Zio LTCM in Commercially Insured Patients at HRS2025Article Thumbnail
Quiver QuantitativeNew Lobbying Disclosure: IRHYTHM TECHNOLOGIES INC. ($IRTC) disclosed spending $60000 lobbying (Issues related to CMS payment policy and telehealth. Issues related to Medicare technology paid pursuant to Medicare physician fee schedule. Issues related to COVID-19.)Article Thumbnail
Quiver QuantitativeNew Insider Disclosure: Turakhia Minang (EVP, CMO & CSO) disclosed 7014 shares sold of $IRTCArticle Thumbnail
Quiver QuantitativeNew Insider Disclosure: Murphy Patrick Michael (CBO and CLO) disclosed 16330 shares sold of $IRTCArticle Thumbnail
Quiver QuantitativeNew Insider Disclosure: Wilson Daniel G. (Chief Financial Officer) disclosed 2512 shares sold of $IRTCArticle Thumbnail
Quiver QuantitativeNew Insider Disclosure: Shrishrimal Sumi (EVP, Chief Risk Officer) disclosed 7942 shares sold of $IRTCArticle Thumbnail
Quiver QuantitativeNew Insider Disclosure: Patterson Chad (Chief Commercial Officer) disclosed 13690 shares sold of $IRTCArticle Thumbnail
Quiver QuantitativeNew Insider Disclosure: Blackford Quentin S. (President and CEO) disclosed 22252 shares sold of $IRTCArticle Thumbnail
$IRTC stock is up 8% today. Here's what we see in our data.Article Thumbnail
iRhythm Technologies Reports 24% Revenue Growth in Q4 2024 and Updates Financial Guidance for 2025Article Thumbnail
Lobbying Update: $60,000 of IRHYTHM TECHNOLOGIES INC. lobbying was just disclosedArticle Thumbnail
Quiver QuantitativeNew Lobbying Disclosure: IRHYTHM TECHNOLOGIES INC. ($IRTC) disclosed spending $60000 lobbying (Issues related to CMS payment policy and telehealth. Issues related to Medicare technology paid pursuant to Medicare physician fee schedule. Issues related to COVID-19.)Article Thumbnail
iRhythm Technologies Announces Preliminary Fourth Quarter Highlights and 2025 Revenue Outlook at J.P. Morgan Healthcare ConferenceArticle Thumbnail
Insider Sale: CBO and CLO of $IRTC (IRTC) Sells 2,492 SharesArticle Thumbnail
Quiver QuantitativeNew Insider Disclosure: Murphy Patrick Michael (CBO and CLO) disclosed 2492 shares sold of $IRTCArticle Thumbnail
iRhythm Technologies Presents New Research Findings on Ambulatory Cardiac Monitoring at AHA 2024 Scientific SessionsArticle Thumbnail
Quiver QuantitativeInsider Purchase: Director at Irhythm Technologies (IRTC) Buys 6,664 SharesArticle Thumbnail
Quiver QuantitativeNew Insider Disclosure: Blackford Quentin S. (President and CEO) disclosed 16145 shares sold of $IRTCArticle Thumbnail
Quiver QuantitativeNew Lobbying Disclosure: IRHYTHM TECHNOLOGIES ($IRTC) disclosed spending $10000 lobbying (Issues related to artificial intelligence. )Article Thumbnail
Quiver QuantitativeNew Lobbying Disclosure: IRHYTHM TECHNOLOGIES INC. ($IRTC) disclosed lobbying (Issues related to CMS payment policy, telehealth.)Article Thumbnail
Quiver QuantitativeNew Insider Disclosure: Bobzien Brice (Chief Financial Officer) disclosed 1372 shares sold of $IRTCArticle Thumbnail
Quiver QuantitativeNew Insider Disclosure: Smith Mervin (EVP Strategic Business Ops) disclosed 688 shares sold of $IRTCArticle Thumbnail
Quiver QuantitativeNew Insider Disclosure: Patterson Chad (Chief Commercial Officer) disclosed 2732 shares sold of $IRTCArticle Thumbnail
Quiver QuantitativeNew Lobbying Disclosure: IRHYTHM TECHNOLOGIES ($IRTC) disclosed spending $60000 lobbying (Issues related to artificial intelligence. )Article Thumbnail
Quiver QuantitativeNew Insider Disclosure: Turakhia Minang (EVP, CMO & CSO) disclosed 1404 shares sold of $IRTCArticle Thumbnail
CNBC Recommendations

Recent picks made for IRTC stock on CNBC

Top ETF Holders

ETFs with the largest estimated holdings in IRTC

IRTC Analyst Ratings

IRTC Stock Forecasts
...

  • ... Highest Price Target
  • ... Median Price Target
  • ... Lowest Price Target
IRTC Analyst Forecasts
Analyst
Firm
Current
Previous
Date
Frequently Asked Questions
  • Is $IRTC stock a Buy, Sell, or Hold?

  • What is the price target for $IRTC stock?

* Analyst consensus is not financial advice. Please see our data disclaimers .

IRTC Top Shareholders
Shareholder
Shares Held
IRTC Options Owners
Shareholder
Security
Underlying Shares
Frequently Asked Questions
  • Who owns $IRTC stock?

  • Who owns the most shares of $IRTC stock?

  • What funds own $IRTC stock?

* These are estimates based on data taken from SEC filings. There may be inaccuracies due to parsing errors, accidental double-counting, incorrect classification of indirectly owned shares, or any other number of issues.

IRTC Stock Smart Score

The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.

The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.
?

Sign Up to view IRTC Smart Score

Score Breakdown
Bull Case vs Bear Case

See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.

Example:

Bulls Say:

The Bulls Say summary highlights positive aspects of the stock.

Bears Say:

The Bears Say summary points out potential risks and negative aspects of the stock.

Bull Case vs Bear Case data is only available to Quiver Premium subscribers.

Back To Top